Chiome Bioscience Inc. 4583Short Interest
Estimated short interest in Chiome Bioscience Inc. (4583) is 3.12% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Barclays Capital Securities Ltd, Morgan Stanley MUFG Securities Co., Ltd., Arrowstreet Capital, Limited Partnership.
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 1 institutions whose last report is more than a year old (1.19% in total). It also excludes 15 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-09-01 |
|---|---|
| Latest disclosure | 2026-11-17 (Morgan Stanley MUFG Securities Co., Ltd., 0.98%) |
| Reporting institutions | 20 firms (2459 reports) |
| Peak estimated short interest | 19.19% (2025-01-31, 10 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- Morgan Stanley MUFG Securities Co., Ltd.
- Arrowstreet Capital, Limited Partnership
- GOLDMAN SACHS INTERNATIONAL
- Nomura International plc
- Others
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-16 | Barclays Capital Securities Ltd | Position 1,283,160 shares | Ratio 1.56% | ▼0.08% | Holding |
| 2024-02-02 | Arrowstreet Capital ESG Global Equity Long/Short Fund Limited | Position 645,600 shares | Ratio 1.19% | ▼0.06% | No report for 1+ year |
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 808,594 shares | Ratio 0.98% | ▼0.06% | Holding |
| 2026-09-29 | Arrowstreet Capital, Limited Partnership | Position 480,500 shares | Ratio 0.58% | ▼0.07% | Holding |
| 2025-07-09 | GOLDMAN SACHS INTERNATIONAL | Position 337,031 shares | Ratio 0.49% | ▼0.06% | Below 0.5% |
| 2024-10-09 | Nomura Securities Co., Ltd. | Position 295,900 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2025-06-24 | BNP Paribas Financial Markets SNC | Position 339,700 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2026-02-19 | JPM Securities Japan Co Ltd. | Position 339,300 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2026-10-13 | MERRILL LYNCH INTERNATIONAL | Position 390,200 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2021-07-08 | Deutsche Bank Aktiengesellschaft, London | Position 187,200 shares | Ratio 0.46% | ▼0.22% | Below 0.5% |
| 2021-01-28 | JANE STREET GLOBAL TRADING, LLC | Position 186,100 shares | Ratio 0.46% | ▼0.05% | Below 0.5% |
| 2021-12-16 | Credit Suisse AG | Position 183,056 shares | Ratio 0.45% | ▼0.12% | Below 0.5% |
| 2019-11-20 | Credit Suisse Securities (Europe) Limited | Position 149,756 shares | Ratio 0.44% | ▼0.36% | Below 0.5% |
| 2026-09-24 | Nomura International plc | Position 353,300 shares | Ratio 0.43% | ▼0.10% | Below 0.5% |
| 2024-12-13 | Citigroup Global Markets Limited | Position 237,200 shares | Ratio 0.35% | ▼0.15% | Below 0.5% |
| 2025-06-11 | UBS AG | Position 229,500 shares | Ratio 0.33% | ▼0.19% | Below 0.5% |
| 2022-09-27 | SMBC Nikko Securities Inc. | Position 140,900 shares | Ratio 0.31% | ▼0.32% | Below 0.5% |
| 2025-02-14 | XTX Markets Pte Ltd | Position 213,300 shares | Ratio 0.31% | ▼0.23% | Below 0.5% |
| 2018-03-15 | OXAM QUANT FUND LIMITED | Position 55,500 shares | Ratio 0.21% | ▼0.35% | Below 0.5% |
| 2026-08-18 | Mizuho Securities Co., Ltd. | Position 0 shares | Ratio 0.00% | ▼0.64% | Closed |
Disclosure History 2459 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 808,594 shares | Ratio 0.98% | ▼0.06% | — |
| 2026-11-16 | Barclays Capital Securities Ltd | Position 1,283,160 shares | Ratio 1.56% | ▼0.08% | — |
| 2026-11-12 | Barclays Capital Securities Ltd | Position 1,348,160 shares | Ratio 1.64% | ▼0.08% | — |
| 2026-11-11 | Barclays Capital Securities Ltd | Position 1,411,760 shares | Ratio 1.72% | ▲0.08% | — |
| 2026-11-11 | Morgan Stanley MUFG Securities Co., Ltd. | Position 855,794 shares | Ratio 1.04% | ▲0.05% | — |
| 2026-11-10 | Barclays Capital Securities Ltd | Position 1,349,160 shares | Ratio 1.64% | ▼0.09% | — |
| 2026-11-10 | Morgan Stanley MUFG Securities Co., Ltd. | Position 816,894 shares | Ratio 0.99% | ▲0.11% | — |
| 2026-11-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 721,894 shares | Ratio 0.88% | ▼0.06% | — |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 1,422,360 shares | Ratio 1.73% | ▲0.05% | — |
| 2026-11-06 | Morgan Stanley MUFG Securities Co., Ltd. | Position 775,294 shares | Ratio 0.94% | ▼0.14% | — |
| 2026-11-05 | Morgan Stanley MUFG Securities Co., Ltd. | Position 884,994 shares | Ratio 1.08% | ▼0.03% | — |
| 2026-11-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 913,694 shares | Ratio 1.11% | ▼0.12% | — |
| 2026-11-02 | Barclays Capital Securities Ltd | Position 1,379,660 shares | Ratio 1.68% | ▼0.08% | — |
| 2026-10-29 | Barclays Capital Securities Ltd | Position 1,448,360 shares | Ratio 1.76% | ▼0.13% | — |
| 2026-10-28 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,014,894 shares | Ratio 1.23% | ▲0.07% | — |
| 2026-10-27 | Barclays Capital Securities Ltd | Position 1,549,160 shares | Ratio 1.89% | ▼0.05% | — |
| 2026-10-23 | Barclays Capital Securities Ltd | Position 1,595,860 shares | Ratio 1.94% | ▲0.18% | — |
| 2026-10-23 | Morgan Stanley MUFG Securities Co., Ltd. | Position 953,994 shares | Ratio 1.16% | ▼0.33% | — |
| 2026-10-21 | Barclays Capital Securities Ltd | Position 1,448,460 shares | Ratio 1.76% | ▼0.05% | — |
| 2026-10-20 | Barclays Capital Securities Ltd | Position 1,482,660 shares | Ratio 1.81% | ▲0.22% | — |
| 2026-10-20 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,227,394 shares | Ratio 1.49% | ▲0.23% | — |
| 2026-10-19 | Barclays Capital Securities Ltd | Position 1,308,260 shares | Ratio 1.59% | ▼0.06% | — |
| 2026-10-15 | Barclays Capital Securities Ltd | Position 1,358,160 shares | Ratio 1.65% | ▼0.06% | — |
| 2026-10-14 | Barclays Capital Securities Ltd | Position 1,401,060 shares | Ratio 1.71% | ▲0.02% | — |
| 2026-10-13 | MERRILL LYNCH INTERNATIONAL | Position 390,200 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2026-10-13 | Barclays Capital Securities Ltd | Position 1,389,560 shares | Ratio 1.69% | ▼0.09% | — |
| 2026-10-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,035,194 shares | Ratio 1.26% | ▼0.08% | — |
| 2026-10-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,097,494 shares | Ratio 1.34% | ▲0.06% | — |
| 2026-10-08 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,051,394 shares | Ratio 1.28% | ▲0.13% | — |
| 2026-10-08 | MERRILL LYNCH INTERNATIONAL | Position 411,000 shares | Ratio 0.50% | ▲0.05% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| D.Western Therapeutics Institute, Inc.4576 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Daito Pharmaceutical Co.,Ltd.4577 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| Otsuka Holdings Co.,Ltd.4578 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| RaQualia Pharma Inc.4579 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SymBio Pharmaceuticals Limited4582 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Medrx Co.,Ltd.4586 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PeptiDream Inc.4587 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Oncolys BioPharma Inc.4588 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| RIBOMIC Inc.4591 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |